Sinotherapeutics (SH:688247) Xin Lang Cai Jing·2025-08-17 08:41Core Viewpoint - The company, Xuantai Pharmaceutical (688247), announced a commitment from its controlling shareholder, Lianhe Investment, to not reduce its shareholding through various trading methods for a period of 24 months, starting from August 25, 2025, to enhance investor confidence and maintain market stability [1] Summary by Relevant Categories Company Commitment - Lianhe Investment, the controlling shareholder, voluntarily pledged to refrain from selling its shares in the company through centralized bidding or block trading for 24 months [1] Investor Confidence - The commitment aims to bolster investor confidence and protect the rights of investors, reflecting the company's confidence in its future development prospects and long-term value [1]